Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nicotine | 11 | 2021 | 113 | 1.950 |
Why?
|
| Interpeduncular Nucleus | 8 | 2024 | 21 | 1.680 |
Why?
|
| Ventral Tegmental Area | 10 | 2023 | 33 | 1.470 |
Why?
|
| Receptors, Nicotinic | 13 | 2016 | 66 | 1.420 |
Why?
|
| Nicotinic Agonists | 7 | 2017 | 39 | 1.170 |
Why?
|
| Substance Withdrawal Syndrome | 5 | 2021 | 119 | 0.930 |
Why?
|
| Dopamine | 8 | 2024 | 102 | 0.920 |
Why?
|
| Habenula | 4 | 2020 | 15 | 0.900 |
Why?
|
| GABAergic Neurons | 5 | 2024 | 31 | 0.700 |
Why?
|
| Anxiety | 5 | 2023 | 387 | 0.600 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2016 | 34 | 0.510 |
Why?
|
| Mice, Inbred C57BL | 13 | 2023 | 3231 | 0.420 |
Why?
|
| Mice | 21 | 2024 | 10291 | 0.390 |
Why?
|
| Dopaminergic Neurons | 5 | 2023 | 32 | 0.380 |
Why?
|
| Neurons | 4 | 2012 | 863 | 0.330 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2009 | 20 | 0.330 |
Why?
|
| Parkinsonian Disorders | 1 | 2009 | 14 | 0.330 |
Why?
|
| Animals | 22 | 2024 | 19650 | 0.300 |
Why?
|
| Reward | 4 | 2023 | 83 | 0.280 |
Why?
|
| Mecamylamine | 4 | 2021 | 14 | 0.270 |
Why?
|
| Nerve Net | 2 | 2017 | 93 | 0.250 |
Why?
|
| Ethanol | 4 | 2013 | 306 | 0.250 |
Why?
|
| Nicotinic Antagonists | 3 | 2013 | 19 | 0.220 |
Why?
|
| Mice, Transgenic | 5 | 2019 | 1206 | 0.180 |
Why?
|
| MicroRNAs | 2 | 2020 | 616 | 0.180 |
Why?
|
| Motivation | 1 | 2023 | 274 | 0.180 |
Why?
|
| RNA, Messenger | 2 | 2020 | 1466 | 0.170 |
Why?
|
| Male | 13 | 2021 | 27749 | 0.170 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2019 | 37 | 0.150 |
Why?
|
| Corpus Striatum | 1 | 2019 | 93 | 0.150 |
Why?
|
| Synaptic Transmission | 2 | 2024 | 147 | 0.150 |
Why?
|
| Cocaine | 1 | 2019 | 96 | 0.150 |
Why?
|
| Sex Characteristics | 1 | 2019 | 197 | 0.140 |
Why?
|
| Signal Transduction | 3 | 2017 | 2900 | 0.140 |
Why?
|
| Tyrosine 3-Monooxygenase | 3 | 2015 | 33 | 0.140 |
Why?
|
| Action Potentials | 3 | 2015 | 101 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-fos | 3 | 2015 | 52 | 0.140 |
Why?
|
| Exploratory Behavior | 1 | 2017 | 33 | 0.140 |
Why?
|
| Paternal Exposure | 1 | 2017 | 5 | 0.140 |
Why?
|
| Paternal Inheritance | 1 | 2017 | 6 | 0.140 |
Why?
|
| Xenobiotics | 1 | 2017 | 13 | 0.140 |
Why?
|
| Gene Silencing | 1 | 2019 | 378 | 0.130 |
Why?
|
| Choice Behavior | 1 | 2017 | 78 | 0.130 |
Why?
|
| Cholinergic Neurons | 1 | 2016 | 10 | 0.130 |
Why?
|
| Mice, Knockout | 4 | 2016 | 1994 | 0.120 |
Why?
|
| Protein Subunits | 2 | 2013 | 165 | 0.120 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2015 | 24 | 0.120 |
Why?
|
| Environmental Exposure | 1 | 2017 | 208 | 0.120 |
Why?
|
| Anxiety Disorders | 1 | 2016 | 186 | 0.120 |
Why?
|
| Ion Channels | 1 | 2014 | 88 | 0.110 |
Why?
|
| Tobacco Use Disorder | 1 | 2016 | 243 | 0.110 |
Why?
|
| Up-Regulation | 1 | 2015 | 365 | 0.110 |
Why?
|
| Rhodopsin | 1 | 2013 | 13 | 0.110 |
Why?
|
| Somatostatin | 1 | 2013 | 18 | 0.110 |
Why?
|
| Phototherapy | 1 | 2013 | 34 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 2 | 2013 | 418 | 0.110 |
Why?
|
| Acetylcholine | 2 | 2012 | 41 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2014 | 248 | 0.110 |
Why?
|
| Glutamic Acid | 1 | 2013 | 95 | 0.110 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2013 | 75 | 0.100 |
Why?
|
| Analysis of Variance | 2 | 2011 | 589 | 0.100 |
Why?
|
| Light | 1 | 2013 | 198 | 0.100 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2011 | 3 | 0.090 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2011 | 5 | 0.090 |
Why?
|
| Bicuculline | 1 | 2011 | 6 | 0.090 |
Why?
|
| Microdissection | 1 | 2011 | 5 | 0.090 |
Why?
|
| Atropine | 1 | 2011 | 13 | 0.090 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2011 | 30 | 0.090 |
Why?
|
| Cell Size | 1 | 2011 | 40 | 0.090 |
Why?
|
| Cell Count | 1 | 2011 | 127 | 0.090 |
Why?
|
| Patch-Clamp Techniques | 1 | 2011 | 126 | 0.090 |
Why?
|
| Electric Stimulation | 1 | 2011 | 131 | 0.090 |
Why?
|
| Muscarinic Antagonists | 1 | 2011 | 32 | 0.090 |
Why?
|
| Drug Interactions | 1 | 2011 | 115 | 0.090 |
Why?
|
| Benzazepines | 1 | 2010 | 21 | 0.090 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 1552 | 0.090 |
Why?
|
| Quinoxalines | 1 | 2010 | 35 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2015 | 805 | 0.080 |
Why?
|
| In Vitro Techniques | 1 | 2011 | 472 | 0.080 |
Why?
|
| Catalepsy | 1 | 2009 | 2 | 0.080 |
Why?
|
| Cholinergic Fibers | 1 | 2009 | 4 | 0.080 |
Why?
|
| Quinpirole | 1 | 2009 | 5 | 0.080 |
Why?
|
| Epilepsy, Generalized | 1 | 2009 | 4 | 0.080 |
Why?
|
| Muscle Rigidity | 1 | 2009 | 7 | 0.080 |
Why?
|
| Multigene Family | 1 | 2010 | 92 | 0.080 |
Why?
|
| Dopamine Agonists | 1 | 2009 | 20 | 0.080 |
Why?
|
| Interneurons | 1 | 2009 | 22 | 0.080 |
Why?
|
| Temperature | 1 | 2011 | 295 | 0.080 |
Why?
|
| Tremor | 1 | 2009 | 23 | 0.080 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 124 | 0.080 |
Why?
|
| Alcoholic Intoxication | 1 | 2009 | 27 | 0.080 |
Why?
|
| Carcinoma | 1 | 2010 | 116 | 0.080 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 297 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 234 | 0.080 |
Why?
|
| Organ Culture Techniques | 2 | 2019 | 68 | 0.080 |
Why?
|
| Alcohol Drinking | 1 | 2010 | 288 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 689 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 676 | 0.060 |
Why?
|
| Tegmentum Mesencephali | 1 | 2024 | 6 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 584 | 0.060 |
Why?
|
| Sucrose | 1 | 2023 | 28 | 0.050 |
Why?
|
| Nucleus Accumbens | 1 | 2023 | 42 | 0.050 |
Why?
|
| Mesencephalon | 1 | 2020 | 25 | 0.040 |
Why?
|
| Profilins | 1 | 2020 | 45 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 194 | 0.040 |
Why?
|
| Locomotion | 1 | 2019 | 111 | 0.040 |
Why?
|
| Dopamine Antagonists | 1 | 2017 | 15 | 0.040 |
Why?
|
| Optogenetics | 1 | 2017 | 22 | 0.040 |
Why?
|
| Maze Learning | 1 | 2017 | 50 | 0.030 |
Why?
|
| Inactivation, Metabolic | 1 | 2017 | 14 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2019 | 587 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2017 | 95 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 718 | 0.030 |
Why?
|
| Calbindin 2 | 1 | 2015 | 3 | 0.030 |
Why?
|
| Calbindins | 1 | 2015 | 10 | 0.030 |
Why?
|
| Dihydro-beta-Erythroidine | 1 | 2015 | 4 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 554 | 0.030 |
Why?
|
| Glutamate Decarboxylase | 1 | 2015 | 21 | 0.030 |
Why?
|
| Conditioning, Operant | 1 | 2015 | 26 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2015 | 128 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2019 | 2092 | 0.030 |
Why?
|
| Mutation | 2 | 2015 | 2456 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2014 | 89 | 0.030 |
Why?
|
| Emotions | 1 | 2016 | 215 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2014 | 183 | 0.030 |
Why?
|
| Ligands | 1 | 2014 | 411 | 0.030 |
Why?
|
| Mammals | 1 | 2014 | 209 | 0.030 |
Why?
|
| Female | 2 | 2017 | 30726 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2012 | 34 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2012 | 132 | 0.020 |
Why?
|
| Liver | 1 | 2017 | 795 | 0.020 |
Why?
|
| Drinking Behavior | 1 | 2010 | 9 | 0.020 |
Why?
|
| Varenicline | 1 | 2010 | 11 | 0.020 |
Why?
|
| Alanine | 1 | 2010 | 49 | 0.020 |
Why?
|
| Leucine | 1 | 2010 | 61 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2010 | 147 | 0.020 |
Why?
|
| Central Nervous System Depressants | 1 | 2010 | 42 | 0.020 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2010 | 16 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2015 | 737 | 0.020 |
Why?
|
| Darkness | 1 | 2009 | 22 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 188 | 0.020 |
Why?
|
| Binding Sites | 1 | 2010 | 881 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 474 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 650 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 847 | 0.020 |
Why?
|
| Brain | 1 | 2014 | 1488 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 1368 | 0.020 |
Why?
|
| Humans | 3 | 2019 | 59389 | 0.010 |
Why?
|
| Smoking | 1 | 2010 | 826 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 2050 | 0.010 |
Why?
|